The Genesys Venture Team

Management

Albert D. Friesen, Ph.D

Albert D. Friesen, Ph.D

Albert D. Friesen, Ph.D - President

Albert D. Friesen holds a Ph.D. in Protein Chemistry from the University of Manitoba. He has been instrumental in founding and the development of several health industry companies including ABI Biotechnology Canada's first profitable Biotech Company, (now Apotex Fermentation). Dr. Friesen also led development of Canada's first biotech product, WinRho at Winnipeg Rh Institute Inc./Rh Pharmaceuticals (now Cangene) and is a founder of the Industrial Biotechnology Association of Canada (now BIOTECanada).

Genesys Venture Inc., (GVI) which provides the expertise to start-up and manage emerging health and biotechnology ventures, was founded by Dr. Friesen. GVI has been responsible for the start up of many successful companies including Diamedica Inc., Kane Biotech and Miraculins Inc. Dr. Friesen led establishment of CentreStone Venture Partners, a $22 million life science fund based in Winnipeg.

Marcus Enns, B.Comm. (Hons.)

Marcus Enns, B.Comm. (Hons.)

Marcus Enns, B.Comm. (Hons.) - Vice President, Corporate Affairs

Marcus Enns obtained his Bachelor of Commerce (Hons.) degree from the University of Manitoba. He was previously employed in the banking industry where he gained valuable experience in lending and financial management. Mr. Enns joined the GVI team in 2000 and is currently Vice President, Corporate Affairs. In this capacity he oversees treasury activities and contract administration and plays a major role in both private and public fundraising activities involving GVI's client companies. Mr. Enns held executive positions with two TSX Venture Exchange listed companies, Miraculins Inc. and Kane Biotech Inc. and was involved with bringing both companies public in 2002 and 2003 respectively. Mr. Enns is currently Chair of the Board for the Rosenort Credit Union.

James Kinley, CA

James Kinley, CA

James Kinley, CA - Vice President, Finance

Mr. Kinley is responsible for the financial operations of GVI and its client companies, including the financial reporting and continuous disclosure re-posting requirements for publicly traded companies. Previously, Mr. Kinley was Manager, Financial Reporting at Manitoba Telecom Services Ltd. (MTS).  His responsibilities included the review and distribution of external quarterly and annual financial statements, internal financial statements and board reporting packages.  He was also significantly involved in the conversion from Canadian Generally Accepted Accounting Principles (GAAP) to International Financial Reporting Standards (IFRS).  Mr. Kinley has extensive experience working with publically traded entities, having provided financial reporting services for a number of stock exchange listed real estate investment trusts (REITs) from 2006 to 2008. Prior to this time he was an Audit Senior at Ernst & Young, LLP.  Mr. Kinley is a Chartered Accountant and holds a B.Comm (Honours) degree from the I.H. Asper School of Business (University of Manitoba).


Consultant Resources

George Thomas, Ph.D

George Thomas, Ph.D

George Thomas, Ph.D - Director, Research & Development

Dr. Thomas has over 15 years of experience in research leadership and strategic planning in the areas of bio-pharma R&D, molecular diagnostics and therapeutic target discovery and validation. Dr. Thomas has held senior executive positions at Torrent Pharmaceuticals Research Centre, India, where he led teams responsible for setting up in vitro and in vivo assays, managing outsourced studies, pharmacokinetic and toxicological studies and clinical trials. In addition, he has been responsible for the scientific evaluation of various assays/technologies for license or acquisition from industry and academia. In his role with CentreStone Ventures, a life science focused venture capital fund, Dr. Thomas has been actively involved in the scientific assessment and feasibility of various business opportunities, sourcing new opportunities, and taking leadership positions with investee companies. Dr. Thomas received his Master of Pharmacy degree and Ph.D. from the Birla Institute of Technology and Sciences, Pilani, India. He received his post-doctoral training at the Faculty of Medicine, University of Toronto.

Michael Janzen, Ph.D - Director, Scientific & Medical Affairs

Sandra Reis - Director, Regulatory Affairs